Abstract
Introduction

39
Drug effects on ion currents affecting the cardiac ventricular repolarization are well understood on the 40 cellular level. On the ECG level, QTc prolongation is an established surrogate marker for Torsade-de-41 Pointes (TdP), and was introduced as an electrocardiographic biomarker standard for pro-arrhythmic 42 risk assessment via regulatory pathways in 2005 [1] . Since that time, no drugs have been withdrawn 43 from the market due to unexpected induction of TdP, demonstrating that QTc shows good sensitivity in 44 identifying potentially dangerous compounds. However, a major point of criticism relates to the well-45 known lack of specificity of QTc, which may result in early discontinuation of promising candidate . However, the predictive value of changes in ECG morphology has not 52 been established [1] , and little is known about how such morphological parameters are linked to the 53 electrophysiological process at the cellular level [10] . 
Evaluation of drug effects
178
The T vector trajectory quantiles TrXc described above are the basis for our evaluation of drug effects 179 on ventricular repolarization. In order to quantify a drug effect, single-delta parameter values were 180 calculated as , with as the average parameter value of the
181 replicate ECGs at time t under treatment TR for a given subject, and t 0 as the baseline time point.
182 Double-delta parameter values were calculated as .
We modeled the dependencies of the T vector trajectory quantile parameters on the drug 184 concentrations through the mixed effects models (for single drugs in
Study A) respectively (for multiple drugs in Study
, where is the placebo corrected change from baseline of the parameter P, and C, C1, C2 are ∆∆ 187 the drug concentrations. The zero terms in both models enforce the regression line or plane to 188 intersect with the origin. Table 1 ). The prediction's 95% 194 confidence intervals were calculated through a bootstrap simulation. 230 Keeping in mind that T peak is typically located roughly in the middle of the J-T end interval, we likewise 231 expect a relation between the J-T peak interval and the central T vector trajectory quantiles. This is 232 addressed by visually comparing the drug effects of J-T peak to Tr50 and Tr60 for both studies A and B.
233
In order to be consistent with existing literature, the heart rate corrected J-T peak intervals were taken 234 from the published study data. (Fig 2 left column) the slopes in all four graphs are positive. The 241 remaining three compounds show a negative slope for Tr30c (Fig 2, row 1 , columns 2-4). 
261
The effect on the y-axis denotes the placebo-corrected changes from baseline of the T vector 262 trajectory quantiles in milliseconds (corrected for heart rate) with their 95% confidence intervals at the following drug concentrations: dofetilide: 2500 pg/mL, quinidine: 1500 ng/mL, ranolazine: 2000 ng/mL, 264 verapamil: 100 ng/mL. 
281
The effect on the y-axis denotes the placebo-corrected changes from baseline of the T vector 282 trajectory quantiles in milliseconds (corrected for heart rate) with their 95% confidence intervals at the 283 drug concentrations as given in Table 1 .
285
Figs 5 and 6 demonstrate that the double-delta changes of the 100% T vector trajectory quantiles are 286 comparable in size and precision to the double-delta changes of QTcF for all treatments. The highest 287 correlation with the published J-T peak data was observed for the 50% and 60% T vector trajectory 288 quantiles. Table 2 compares the median values and interquartile ranges of the three parameters for 289 the drug-free cases, and shows that the effect size of J-T peak lies between the 50% and 60% quantiles.
290
This also holds for the majority of the cases under treatment (Figs 5 and 6) . Notably, most confidence 291 intervals for J-T peak c were larger than those of the 50% and 60% T vector trajectory quantiles. 
Interpretation of T vector trajectory quantiles
327
In this study, we used heart rate corrected quantiles of the heart's dipole vector trajectory along the T 328 wave loop as a new set of ECG biomarkers for assessing drug effects on the repolarization process.
329
The profile level comparable to that of Tr40c. This is in accordance with the limited effect of pure sodium 364 ion channel block onto phase 3 of the AP in our simulation (Fig 9) . Overall, this indicates that the slight 365 QTcF shortening effect of these two drugs is mainly caused by an acceleration of early repolarization, 366 which then is largely maintained. 
